Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00085332 · ClinicalTrials.gov registry record · Phase 2
Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
A Phase 2 study, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00085332: Completed Phase 2 study, sponsored by Gynecologic Oncology Group.
NCT00085332 is a Phase 2 study that has completed, run by Gynecologic Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00085332, a Phase 2 study, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well docetaxel works in treating patients with recurrent or persistent endometrial carcinoma (cancer).
Interventions
- DRUG docetaxel
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-07 |
| Phase | Phase 2 |
What the finished NCT00085332 record still lists
NCT00085332 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which docetaxel is the first listed.
NCT00085332 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00085332 about?
NCT00085332 is a clinical study titled "Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)". RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well docetaxel works in treating patients with recurrent or persistent endometrial carcinoma (cancer).
What is the current status of trial NCT00085332?
This trial is currently completed. It is a Phase 2 study. The study started on 2004-07.
What interventions are being tested in trial NCT00085332?
The interventions under investigation include: docetaxel (DRUG).
Who is sponsoring clinical trial NCT00085332?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia